ABSTRACT
Although multiregional clinical trials (MRCTs) have gained extensive use in contemporary drug development with the intrinsic underlying assumption that drug effectiveness and safety are the same across regions, regional differences in other aspects can also make interpretation of MRCT results challenging. In this chapter, we discuss four types of regional differences and associated statistical challenges: endpoint differences, background event rate differences, control therapy differences, and geographic population shift.
